Clinical Trial Update: Abiomed Impella RT-DAQ - Observational Study

View source ↗

Summary

Update on an observational study of Abiomed's Impella RT-DAQ for cardiogenic shock. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Impella RT-DAQ

Snippet

Sponsor: Abiomed Inc. | Conditions: Cardiogenic Shock | Status: ACTIVE_NOT_RECRUITING